Regenxbio Inc (RGNX)

R&D Expenses

$56.09M

Quarterly · Period ending: · USD

RGNX logo

RGNX R&D Expenses

Latest reported$56.09M
RGNX Quarterly R&D Expenses ($937.00K → $56.09M)
High-resolution chart · PNG

RGNX r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regenxbio Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
56,086,000
57,339,000
59,611,000
56,101,000
55,595,000
53,087,000
50,380,000
54,429,000
44,818,000
50,664,000
51,346,000
58,183,000
59,886,000
58,516,000
62,505,000
63,313,000
61,008,000
55,627,000
47,978,000
47,855,000
45,882,000
39,722,000
47,180,000
43,968,000
38,111,000
37,035,000
33,807,000
35,692,000
29,483,000
25,203,000
24,329,000
18,508,000
21,486,000
19,550,000
14,170,000
12,518,000
13,917,000
16,619,000
16,059,000
12,560,000
10,680,000
6,183,000
4,812,000
5,664,000
4,012,000
2,791,000
2,092,000
1,085,000
850,000
937,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.